Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/20/2003US20030054012 Inducing immunology response; administering to mucous membrane
03/20/2003US20030054011 Anticancer agents
03/20/2003US20030054010 Molecular antigen array
03/20/2003US20030054009 Vaccine; inducing immunology response
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030054005 Using monoclonal antibodies; polymerase chain reactions
03/20/2003US20030054004 In situ diagnosis, therapy; antitumor agent; administering dosage of tumornecrosis factor antibody
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053994 Genetic engineering; desroying infections; antitumor, anticancer agents
03/20/2003US20030053993 Regeneration of nerve cells
03/20/2003US20030053991 Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053988 Genetic engineering; culture product; process control
03/20/2003US20030053987 Synthetic hepatitis c genes
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003US20030053983 Colloidal metal compositions and methods
03/20/2003US20030053982 Interferon attached to water soluble polyethylene glycol
03/20/2003US20030052839 Stabilized viral envelope proteins and uses thereof
03/20/2003CA2472102A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003CA2462574A1 Subunit respiratory syncytial virus vaccine preparation
03/20/2003CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460425A1 Novel nucleic acids and polypeptides
03/20/2003CA2460331A1 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system
03/20/2003CA2460025A1 Attenuated bacteria useful in vaccines
03/20/2003CA2459947A1 Compositions and methods for aa4rp assay
03/20/2003CA2459945A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003CA2459915A1 Blueberry red ringspot virus, sequences, promoters, and uses thereof
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459862A1 Oxyntomodulin for preventing or treating excess weight
03/20/2003CA2459769A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003CA2459586A1 Bacterial cells and vaccines comprising three or more colisurface antigens
03/20/2003CA2459442A1 Nucleic acid-associated proteins
03/20/2003CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof
03/20/2003CA2459373A1 Method of evaluating efficacy of nucleic acid therapy
03/20/2003CA2459367A1 Methods for construction and screening of libraries of chemokine variants
03/20/2003CA2459323A1 G-protein coupled receptors
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459307A1 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003CA2458543A1 Compositions and methods for treatment of cancer
03/20/2003CA2457441A1 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
03/20/2003CA2456310A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2454992A1 Adenoviral vector and related system and methods of making and use
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/20/2003CA2436341A1 Impartment of virus-resistance with the use of plant protein binding to plant virus transport protein
03/19/2003EP1293573A2 Process for producing a marker-vaccine against a mammalian virus
03/19/2003EP1293572A1 Method of altering plant secondary metobolite biosynthesis in plant cells
03/19/2003EP1293571A2 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
03/19/2003EP1293570A2 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
03/19/2003EP1293569A2 Full-length cDNAs
03/19/2003EP1293568A1 Novel protein and dna thereof
03/19/2003EP1293567A1 Ligand to gpr8 and dna thereof
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293513A2 A recombinant human factor VIII derivative
03/19/2003EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype
03/19/2003EP1293511A1 Canine liver cell growth factor
03/19/2003EP1293510A1 Novel polypeptide and its dna
03/19/2003EP1292830A2 Method for identifying insulin mimics or antagonists
03/19/2003EP1292827A1 T2r taste receptors and genes encoding same
03/19/2003EP1292712A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292707A2 Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner
03/19/2003EP1292705A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
03/19/2003EP1292704A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta
03/19/2003EP1292697A2 Method for preparing a physiologically active il-18 polypeptide
03/19/2003EP1292695A2 Gene-regulating conjugates
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292692A2 Hero resistance gene conferring resistance to nematodes
03/19/2003EP1292690A2 Plant-signalling ligand like proteins
03/19/2003EP1292689A1 Regulated gene expression in yeast and methods of use
03/19/2003EP1292688A2 Promoters for regulated gene expression
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292681A1 Antigenic polypeptides
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292677A2 Human hm74-like g protein coupled receptor
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
03/19/2003EP1292673A2 Thrombomodulin analogs for pharmaceutical use
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292618A2 Vip-related peptides for the treatment of sexual disorders in women
03/19/2003EP1292617A1 Novel compounds
03/19/2003EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof
03/19/2003EP1292615A2 Modified morbillivirus v proteins
03/19/2003EP1292614A2 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
03/19/2003EP1292613A2 Chimeric gfp-aequorin as bioluminescent ca?++ reporters at the single cell level
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292337A2 Multivalent platform molecules comprising high molecular weight polyethylene oxide
03/19/2003EP1292334A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
03/19/2003EP1292333A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form
03/19/2003EP1292330A1 Immunostimulating properties of a fragment of tgf- beta
03/19/2003EP1292329A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
03/19/2003EP1292328A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
03/19/2003EP1292327A2 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN
03/19/2003EP1292322A1 Immunosuppressor agent derived from morbillivirus
1 ... 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 ... 2916